Concepedia

Terry Podoll

TP

Statistics

Publications

11

Citations

1K

H-Index

10

Active since

1993

Affiliations

Covance (United States)(Current)

University of Washington

AstraZeneca (United States)

Pearson (United States)

AstraZeneca (Japan)

Terry Podoll is an author at Covance (United States) specializing in pharmacology, hepatic drug metabolism, and medicine.

Publications per year

1993–2022

11

Publications

11

Use of midazolam as a human cytochrome P450 3A probe: I. In vitro-in vivo correlations in liver transplant patients.

Kenneth E. Thummel, Danny D. Shen, Terry Podoll et al. · Journal of Pharmacology and Experimental Therapeutics · 1994 · 356 citations

, , +17

Use of midazolam as a human cytochrome P450 3A probe: II. Characterization of inter- and intraindividual hepatic CYP3A variability after liver transplantation.

Kenneth E. Thummel, Danny D. Shen, Terry Podoll et al. · Journal of Pharmacology and Experimental Therapeutics · 1994 · 223 citations

, , +17

IN VITRO METABOLISM OF CLINDAMYCIN IN HUMAN LIVER AND INTESTINAL MICROSOMES

Michael A. Wynalda, J. Matthew Hutzler, Michael D. Koets et al. · Drug Metabolism and Disposition · 2003 · 102 citations

, , +17

Human liver microsomal enflurane defluorination catalyzed by cytochrome P-450 2E1.

Kenneth E. Thummel, Evan D. Kharasch, Terry Podoll et al. · Drug Metabolism and Disposition · 1993 · 87 citations

, , +17

Bioavailability, Biotransformation, and Excretion of the Covalent Bruton Tyrosine Kinase Inhibitor Acalabrutinib in Rats, Dogs, and Humans

Terry Podoll, Paul G. Pearson, Jerry Evarts et al. · Drug Metabolism and Disposition · 2018 · 72 citations · Full text

, , +14

1–5 of 11